⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dichlorodifluoromethane SCHEMBL2997893 | 0.82 | — | — | |
| SCHEMBL866 | 0.82 | — | — | |
| Carbon Dioxide SCHEMBL22204693 | 0.77 | — | — | |
| Charcoal, Activated SCHEMBL30130135 | 0.77 | — | — | |
| Dichlorodifluoromethane SCHEMBL5014895 | 0.77 | ALDH1A1 (0.30) | — | |
| Fluoride SCHEMBL27295812 | 0.77 | — | — | |
| Trichloromonofluoromethane SCHEMBL4620269 | 0.77 | ALDH1A1 (0.30) | — | |
| Fluoromethane SCHEMBL9059376 | 0.73 | TSHR (0.33) | — | |
| Dichlorotetrafluoroethane SCHEMBL22832126 | 0.73 | — | — | |
| Chloropentafluoroethane SCHEMBL11557068 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023046941-A1 | INHIBITORS OF THE INTERACTION BETWEEN THE ROCK AND PDK1 PROTEIN KINASES | UNIVERSITE PARIS CITE (FR) | 2023-03-30 | — | — | WO | disclosed |
| EP-4125876-A1 | NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND ANTI-INTERFERON EFFECT | Université Paris Cité (FR) | 2023-02-08 | — | — | EP | disclosed |
| EP-4125889-A1 | NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND ANTI-INTERFERON EFFECT | Université Paris Cité (FR) | 2023-02-08 | — | — | EP | disclosed |
| CN-105008360-B | The Pyrazolopyrimidine derivative of therapeutic activity | UCB生物制药私人有限公司 | 2017-09-19 | — | — | CN | disclosed |
| US-20150267171-A1 | ISOLATION OF ADULT MULTIPOTENTIAL CELLS BY TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE | ANGIOBLAST SYSTEMS, INC. (US) | 2015-09-24 | — | — | US | disclosed |
| EP-1417196-B1 | DNA-PK INHIBITORS | CANCER REC TECH LTD (GB) | 2008-10-22 | — | — | EP | disclosed |
| WO-2001055435-A2 | METHODS AND MATERIALS RELATING TO HEMATOPOIETIC CYTOKINE-LIKE POLYPEPTIDES AND POLYNUCLEOTIDES | HYSEQ, INC. (US) | 2001-08-02 | — | — | WO | disclosed |
| EP-1071429-A1 | MAP KINASE INHIBITORS IN THE TREATMENT OF DISORDERS CAUSED BY TNF-ALPHA INDUCED LIPOLYSIS | TRUSTEES OF TUFTS COLLEGE (US) | 2001-01-31 | — | — | EP | disclosed |
| EP-0966443-A1 | HETEROARYL-HEXANOIC ACID AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE INHIBITORS OF MIP-1-ALPHA BINDING TO ITS CCR1 RECEPTOR | PFIZER INC. (US) | 1999-12-29 | — | — | EP | disclosed |
| WO-1999053927-A1 | METHODS FOR TREATING AND PREVENTING INSULIN RESISTANCE AND RELATED DISORDERS | TRUSTEES OF TUFTS COLLEGE (US) | 1999-10-28 | — | — | WO | disclosed |
| WO-1998038167-A1 | HETEROARYL-HEXANOIC ACID AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE INHIBITORS OF MIP-1-ALPHA BINDING TO ITS CCR1 RECEPTOR | PFIZER INC. (US) | 1998-09-03 | — | — | WO | disclosed |